Jobs
-
According to Avillion, the FDA has accepted the company’s NDA for AstraZeneca’s PT027 albuterol/budesonide MDI for the treatment of asthma in patients aged 4 and older for review. In March 2018, Avillion announced that it… Read more . . .
-
Hailie inhaler monitoring system maker Adherium has announced the appointment of Tara Creaven-Capasso as VP of Quality, Regulatory and Clinical Affairs. Creaven-Capasso has been a long-time regulatory affairs consultant; earlier in her career, she also… Read more . . .
-
Gerresheimer has announced that it will manufacture supplies of Iconovo’s IcoOne dry powder inhaler for Phase 3 trials of ISR’s intranasal COVID-19 vaccine and has started the design process for molding and manufacturing the device.… Read more . . .
-
Posted on OINDPnews on May 30, 2022Company: ModernaLocation: Norwood, MA, USA The Role:This role is an exciting opportunity to be a critical part of a team enabling delivery of mRNA at an organization that is… Read more . . .
-
Posted on OINDPnews on May 25, 2022Company: Recipharm Job Description Recipharm is a leading CDMO (contract development and manufacturing organization) in the pharmaceutical industry employing 9,000 employees with headquarters in Sweden. One of Recipharm’s seven research… Read more . . .
-
CDMO Upperton Pharma Solutions, which recently launched a new nasal delivery development platform, has announced that it will invest £15 million in a new 50,000 sq ft facility in Nottingham, UK that will include new… Read more . . .
-
United Therapeutics has announced the FDA’s approval of its NDA for Tyvaso treprostinil DPI for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). United Therapeutics licensed Treprostinil… Read more . . .
-
According to CyanVac subsidiary Blue Lake Biotechnology, the FDA has granted Fast Track designation for the company’s BLB-201 intranasal vaccine against respiratory syncytial virus (RSV) in children under 2 and adults over 60. The vaccine… Read more . . .
-
CDMO Lonza has announced that it is adding dry powder inhaler testing capabilities at its facility in Tampa, FL, USA for increased DPI development capacity. Lonza, which established a Center of Excellence for DPI particle… Read more . . .
-
According to Biohaven Pharmaceuticals, the FDA has accepted the company’s NDA for its zavegepant (BHV-3500) calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the treatment of migraine and has set a PDUFA goal date… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
December 9-December 11: DDL 2026, Edinburgh, Scotland
April 27-30: RDD Europe 2027, Antibes, France
May 12-13: USP Joint Workshop: Quality and Product Performance Testing of Orally Inhaled and Nasal Drug Products, Rockville, MD, USA
June 30: RespireX 2027, Boston, MA, USA